MindBio Lists for Trading on OTCQB Market

Executive Summary

• MindBio Therapeutics Corp. announced that its common shares are now listed for trading on the OTCQB market.
• The listing coincides with the launch of an extended U.S. roadshow promoting its AI‑driven voice technology for drug and alcohol intoxication detection.
• CEO Justin Hanka highlighted the expanded access to U.S. investors interested in AI and predictive health technologies.

Key Details

• Listing: Common shares now trade on the OTCQB market under ticker MBQIF.
• Roadshow: An extended roadshow in the United States will showcase MindBio’s voice‑and‑AI intoxication detection platform to potential investors, partners, and customers.
• Technology Highlight: The company has developed an AI model using >50 million data points that predicts alcohol intoxication from voice alone and estimates blood alcohol concentration; a consumer “Booze AI” app is slated for launch in 2025.
• Enterprise Expansion: MindBio is developing an enterprise version of the platform targeting workplaces, call centres, mental‑health services, and law‑enforcement applications.
• Future Announcements: The company expects to provide updates on new products, market expansions, and commercial opportunities in the near term.
• CEO Quote: “We are pleased to now reach US investors and a much larger investor audience, particularly those US investors interested in AI and predictive health technologies via our OTCQB listing.” – Justin Hanka, CEO

Notable Quotes

• “We are pleased to now reach US investors and a much larger investor audience, particularly those US investors interested in AI and predictive health technologies via our OTCQB listing.” – Justin Hanka, Chief Executive Officer.